Granted Patent B1

US 12,414,775 · App. 18/739,062 · Granted Sep 16, 2025

Inventor: Stephen Griffin (San Jose, CA)

Assignee: Stryker Ireland Technology Ltd

A61B17/12113A61B17/12172A61B90/39A61B2017/1205A61B2090/3966

Abstract

Claims (30)

1. A method of treating an aneurysm, comprising:

determining a size of an aneurysm;

after determining the size of the aneurysm, selecting an occlusion device that is oversized relative to the aneurysm, wherein the occlusion device comprises:

(a) a solid radiopaque marker having a proximal end and a distal end, and

(b) a resilient mesh body extending distally from the distal end of the solid radiopaque marker,

wherein the resilient mesh body is a single layer of a mesh material folded circumferentially and doubled back onto itself to create a fold line around a circumference of the resilient mesh body and a double layer of the mesh material, and

wherein selecting the occlusion device comprises selecting the occlusion device such that a diameter of the resilient mesh body in free air is greater than a diameter of the aneurysm;

delivering, using a delivery device, the occlusion device in a delivery shape to the aneurysm, wherein the occlusion device is compressed by the delivery device when the occlusion device is in the delivery shape; and

deploying the occlusion device from the delivery device into the aneurysm, wherein deploying the occlusion device comprises:

expanding the occlusion device from the delivery shape towards a deployed shape, conforming the resilient mesh body to walls of the aneurysm, and

while conforming the resilient mesh body to the walls of the aneurysm, sealing a neck of the aneurysm by the resilient mesh body and the solid radiopaque marker.

2. The method of claim 1 , wherein, in free air, the resilient mesh body has a height that is between about 10-20 percent of a width of the resilient mesh body.

3. The method of claim 1 , wherein deploying the occlusion device further comprises laying the resilient mesh body flush, in a flattened manner, up against the walls of the aneurysm.

4. The method of claim 1 , wherein, while conforming the resilient mesh body to the walls of the aneurysm and sealing the neck of the aneurysm by the resilient mesh body and the solid radiopaque marker, the resilient mesh body has a low profile configuration that does not fill a majority of space in the aneurysm.

5. The method of claim 4 , wherein the resilient mesh body covers between about 40-80 percent of an inner surface area of an aneurysm.

6. The method of claim 1 , wherein conforming the resilient mesh body to walls of the aneurysm comprises applying, by the resilient mesh body, an opposing pressure to the walls of the aneurysm that is suitable to eliminate a need for additional material for pinning the neck of the aneurysm and for an anchoring mechanism in a parent vessel adjacent to the aneurysm.

7. The method of claim 1 , wherein, when the resilient mesh body is in free air and the deployed shape, a maximum diameter of the resilient mesh body is defined by the fold line.

8. The method of claim 1 , further comprising, responsive to a pressure applied to the occlusion device at the neck of the aneurysm, increasing the diameter of the resilient mesh body to anchor the occlusion device within the aneurysm.

9. The method of claim 1 , wherein the solid radiopaque marker is a solid ring.

10. The method of claim 1 , wherein the solid radiopaque marker comprises a detachment junction to deploy the occlusion device, and wherein deploying the occlusion device from the delivery device into the aneurysm comprises decoupling the delivery device from the occlusion device at the detachment junction.

11. The method of claim 1 , further comprising, after deploying the occlusion device from the delivery device into the aneurysm, using the solid radiopaque marker as an attachment junction to fully retrieve the occlusion device.

12. The method of claim 1 , further comprising, after deploying the occlusion device from the delivery device into the aneurysm, reducing, by the occlusion device, blood flow in the aneurysm by about 60 percent.

13. The method of claim 1 , wherein a wire mesh braid configuration of the resilient mesh body is suitably dense to reduce a blood flow in the aneurysm and lead to stasis of blood and thrombosis in the aneurysm.

14. The method of claim 1 , wherein the distal end of the solid radiopaque marker is approximately equidistant from opposing ends of the resilient mesh body.

15. The method of claim 1 , wherein all folded over ends of the resilient mesh body are within the solid radiopaque marker.

16. The method of claim 1 , wherein the delivery device comprises a micro-catheter.

17. The method of claim 1 , wherein expanding the resilient mesh body comprises opening the resilient mesh body radially outward.

18. The method of claim 1 , wherein responsive to deploying the occlusion device from the delivery device into the aneurysm, the resilient mesh body defines an open-ended spread configuration.

19. The method of claim 18 , wherein the resilient mesh body defines a concavity opposing a dome of the aneurysm when conforming the resilient mesh body to walls of the aneurysm, and sealing the neck of the aneurysm by the resilient mesh body and the solid radiopaque marker.

20. The method of claim 1 , wherein the occlusion device consists of the solid radiopaque marker and the resilient mesh body.

Assignments (2)

Continuity (6)

References Cited (400)